v3.25.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Sales, net of returns and allowances $ 6,616,358 $ 13,094,752
Cost of sales 28,842,087 38,350,545
Gross loss (22,225,729) (25,255,793)
Operating expenses:    
Selling, general and administrative 42,512,129 55,574,740
Research and development 9,149,055 24,467,933
Total operating expenses 51,661,184 80,042,673
Loss from operations (73,886,913) (105,298,466)
Interest expense, net (22,241,781) (8,731,247)
Fair value gain (loss) on warrants (5,778,660) 0
Other income (loss) 0 (10,000,000)
Loss before income taxes (101,907,354) (124,029,713)
Benefit from income taxes 117,061 110,524
Net loss $ (101,790,293) $ (123,919,189)
Net loss per share of common stock - basic (in dollars per share) [1] $ (51.69) $ (149.45)
Net loss per share of common stock - diluted (in dollars per share) [1] $ (51.69) $ (149.45)
Weighted average shares used in computing net loss per share of common stock - basic (in shares) [1] 1,969,285 829,173
Weighted average shares used in computing net loss per share of common stock - diluted (in shares) [1] 1,969,285 829,173
[1] Periods presented have been adjusted to reflect the 2024 Reverse stock split (1-for-20) which was effective June 17, 2024 and the 2025 Reverse stock split (1-for-12.5) which was effective March 17, 2025. Additional information regarding the reverse stock split may be found in Note 1 – Summary of Business and Significant Accounting Principles.

Source